Dr. Pardo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1855 1st Ave
Ste 200B
San Diego, CA 92101Phone+1 619-793-7988Fax+1 619-269-4302
Education & Training
Harvard Medical SchoolPost-Doctoral Fellowship, 1990 - 1994
Massachusetts General HospitalFellowship, Clinical Oncology, 1990 - 1994- Harvard Medical SchoolPost-Doctoral Fellowship, 1989 - 1990
- Massachusetts General HospitalPost-Doctoral Fellowship, 1989 - 1990
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1986 - 1990- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 1986 - 1989
University of California San Francisco School of MedicineClass of 1984
Johns Hopkins UniversityBA/MA, Biophysics, Highest University and Departmental Honors, 1976 - 1980
Certifications & Licensure
CA State Medical License 1986 - 2026
NY State Medical License 1999 - 2024
MA State Medical License 1990 - 2005- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Top Doctor California Magazine, 2021
- The Albert Nelson Marquis Lifetime Achievement Award Marquis Who's Who Publication Board, 2020
Publications & Presentations
PubMed
- 693 citationsCerebral blood volume maps of gliomas : comparison with tumor grade and histologic findingsHannu J. Aronen, I. E. Gazit, David N. Louis, Bradley R. Buchbinder, Francisco S. Pardo
Radiology. 1994-04-01 - 168 citationsAccelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.Markus M. Fitzek, Allan F. Thornton, James D. Rabinov, Michael H. Lev, Francisco S. Pardo
Journal of Neurosurgery. 1999-08-01 - 35 citationsMutant, wild type, or overall p53 expression: freedom from clinical progression in tumours of astrocytic lineageFrancisco S. Pardo, D. W. Hsu, R Zeheb, Jimmy T. Efird, Paul Okunieff
British Journal of Cancer. 2004-10-26
Grant Support
- Cylcin G1/S Expression And Radiation SensitivityNational Cancer Institute2004
- Cylcin G1/S Expression And Radiation SensitivityNational Cancer Institute2003–2004
- Core--Radiation MedicineNational Cancer Institute2001–2002
- G1/S Regulation And Radiation SensitivityNational Cancer Institute1996–1997
- G1/S Regulation And Radiation SensitivityNational Cancer Institute1995
Professional Memberships
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
